MIRASOL: Mirvetuximab in Platinum Resistant Cancer
Mirvetuximab Soravtansine (MIRV) in platinum resistant ovarian cancer
Ovarian Cancer
Immunotherapy in Ovarian Cancer
Recent trials in Ovarian Cancer and Immunotherapy
Surgical technique for Risk Reduction Salpingo-oophorectomy
Do you perform RRSO? What is your technique
Venous Thromboembolism Prevention in Ovarian Cancer
VTE prophylaxis from the start of NACT to the end of treatment can reduce VTE rates by 80%